A Phase I/II Study of GX15-070MS in Untreated CLL
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients
- Status
- TERMINATED
- Phase
- PHASE2
In-Vivo Activated T-Cell Depletion to Prevent GVHD
- Status
- TERMINATED
- Phase
- NA
Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1
Campath Maintenance in Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- NA
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Investigation of the Cylex® ImmuKnow® Assay
- Status
- COMPLETED
- Phase
- N/A
Oral Valganciclovir Versus Valacyclovir
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL
- Status
- TERMINATED
- Phase
- PHASE1
Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older
- Status
- COMPLETED
- Phase
- PHASE2
CFAR Study in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia
- Status
- COMPLETED
- Phase
- N/A
Phase I Trial of Anti-CD74 (hLL1) Antibody Therapy in B Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2